Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1147 of 5804
-
New immune therapy shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis is an early phase trial designed to evaluate the safety, tolerability, and preliminary antitumor activity of RPTR-1-201 in adults with advanced solid tumors. The trial includes dose escalation and dose expansion parts and will evaluate RPTR-1-201 as monotherapy and in combin…
Phase: PHASE1, PHASE2 • Sponsor: Repertoire Immune Medicines • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Blood test could replace gadolinium scans for MS monitoring
Knowledge-focused Recruiting nowReference MRI scan is recommended 6 months after treatment onset in patients with multiple sclerosis (MS), and follow-up scans at 12 months later to monitor subclinical activity. When monitoring treatment response in patients treated with disease modifying treatments (DMTs), the …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a simpler biopsy replace major surgery for inflammatory breast cancer?
Knowledge-focused Recruiting nowThis study will prospectively determine the feasibility and oncological safety of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) in inflammatory breast cancer patients traditionally considered ineligible for SLNB due to locally advanced cancer with skin/c…
Phase: NA • Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New combo aims to boost Pre-Surgery treatment for stomach cancer
Disease control Recruiting nowWith this trial, we aim to evaluate a new combination therapy with tislelizumab and FLOT chemotherapy before surgery (neoadjuvant) for locally advanced, resectable adenocarcinoma of the esophagus or stomach (EGA). The aim of this phase Ib trial is to determine whether this combin…
Phase: PHASE1 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a VR headset make childbirth less painful?
Symptom relief Not yet recruitingThis study is designed to evaluate whether a virtual reality (VR) intervention can help reduce pain and anxiety and improve childbirth satisfaction among laboring women. Eligible participants will be randomly assigned to either a VR intervention group or a control group receivin…
Phase: NA • Sponsor: Wan-Lin Pan • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New shot targets tough blood cancers in early trial
Disease control Recruiting nowThis is a single-arm, open-label study designed to evaluate the safety, tolerability and cellular pharmacokinetic profiles of UTAA07 Injection. It also aims to preliminarily assess the efficacy of the investigational drug in subjects with relapsed/refractory hematolymphoid malign…
Phase: EARLY_PHASE1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New shot aims to fortify fragile bones in brittle bone disease trial
Disease control Recruiting nowThis study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Ultrasound inside arteries could boost leg treatment success
Disease control Recruiting nowThis study will test whether using ultrasound imaging within blood vessels during minimally invasive treatment of leg arteries in patients with peripheral artery disease leads to better clinical outcomes.
Phase: NA • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Ancient acupressure meets modern medicine: can ear stimulation replace standard Anti-Nausea drugs?
Symptom relief Recruiting nowThis study aims to evaluate whether the preventive and suppressive effects of auricular point stimulation combined with dexamethasone on nausea and vomiting induced by the gemcitabine plus paclitaxel protein-bound regimen are non-inferior to the standard antiemetic regimen in pan…
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New hope for veterans with PTSD: personalized therapy and text reminders
Symptom relief Recruiting nowBy doing this research project, the investigators hope to learn which strategies work best to help veterans who are not benefiting from their first PTSD treatment or not completing between-session homework assignments regularly that might improve treatment response. The investiga…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can acupuncture and exercise ease pelvic pain during pregnancy?
Symptom relief CompletedStudy's Objective: this study aimed to discover the effect of combining electroacupuncture with therapeutic exercises on of symphysis pubis dysfunction during pregnancy.A prospective randomized controlled trial that compared 2 groups of participants was executed. 60 primipara and…
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Sound waves aim to quiet fibromyalgia pain
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time …
Phase: NA • Sponsor: SPIRE Therapeutics Inc. • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New drug shows promise for managing short bowel syndrome Long-Term
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to understand the safety and efficacy of twice weekly glepaglutide 10 mg in adult patients with short bowel syndrome (SBS), who were previously enrolled in the EASE SBS 2 or EASE SBS 3 trials. Participants currently on these trials will be able to con…
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Electric pulses could replace surgery for some breast cancers
Disease control Recruiting nowThis is a prospective, open-label, single-arm, exploratory clinical trial conducted at our institution to investigate the use of Irreversible Electroporation (IRE) for the treatment of breast cancer.
Phase: NA • Sponsor: Tian'an Jiang • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
AI joins the fight against lung cancer: can software spot tumors better?
Diagnosis Not yet recruitingThis multicenter pragmatic randomized controlled trial evaluates whether AI-assisted interpretation of low-dose CT (LDCT) improves lung cancer screening performance compared with standard reading. Eligible participants are randomized to AI-assisted or conventional interpretation.…
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New study tests biologic drug guselkumab for ulcerative colitis in chinese patients
Disease control Recruiting nowThe purpose of this study is to assess the measurable changes in health, function, or quality of life (clinical outcomes) after receiving guselkumab in real-world clinical practice amongst Chinese participants with ulcerative colitis (UC; a long-term disease of the large intestin…
Sponsor: Xian-Janssen Pharmaceutical Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Stem Cell-Derived 'Living Drug' takes aim at tough autoimmune conditions
Disease control Not yet recruitingThis study primarily involves the use of BCT301, an anti-CD19 Chemically induced pluripotent stem cell (CiPSC)-derived CAR-iT cells, for the treatment of patients with refractory autoimmune diseases, aiming to evaluate its safety, tolerability, and dose-limiting toxicities(DLT), …
Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New PET scan could slash radiation exposure for tumor patients
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duratio…
Phase: PHASE2 • Sponsor: Akiva Mintz • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New device aims to help ventilator patients breathe easier by scrubbing CO2 from blood
Disease control Recruiting nowPrismaLung+ is a sterile, single-use medical device aimed at performing partial removal of carbon dioxide (CO2) from the patient's venous blood via diffusion through a membrane. The goal of this prospective, open label, randomized controlled study is to evaluate the efficacy and …
Phase: NA • Sponsor: Vantive Health LLC • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug ST-001 tested in lung cancer patients who have run out of options
Disease control Recruiting nowThis study evaluates a fenretinide phospholipid suspension for the treatment of small cell lung cancer (SCLC).
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC